Program

The program runs from 9:00 AM to 4:00 PM (EET/EEST, Finnish time). At the on-site event, you'll have the opportunity to network with colleagues, and we will offer you a light breakfast, lunch and afternoon coffee.

Themes:

• Overview and Current Status of the New EU HTA Regulation
• Experiences from the First Joint Clinical Assessments (JCAs)
• The European Landscape: Progress and Perspectives
• Patient Perspective in HTA at EU and National Level
• National HTA Agencies’ Preparation for the Implementation of the EU HTA Regulation
• Practical Implementation of JCAs and Related Challenges

Speakers: 

Sara Fredriksson Emrooz, Manager Policy, The Swedish Association of the Pharmaceutical Industry, LIF
Ruta Janeckaite, Legal Officer, Directorate-General for Health and Food Safety, European Commission
Akseli Kivioja, HEMAR Manager/HTA Strategy Lead, Johnson & Johnson
Tuomas Oravilahti, Chief Specialist, Finnish Medicines Agency Fimea
Tatu Sainio, Market Access Director & Commercial Lead, Finland, Bristol Myers Squibb
Matteo Scarabelli, Associate Director, Market Access, EFPIA  European Federation of Pharmaceutical Industries and Associations
Mirjami Tran Minh, Senior Planning Officer, Finnish Cancer Center FICAN


More speakers coming soon!